Hovione Buys Pfizer's Loughbeg AP...(nd less expensively to the benefitof all...)

Date:12/11/2008

nd less expensively to the benefit of all stake-holders. However achieving this goal requires the ability to produce multiple small production campaigns -many simultaneously-, the skill to do rapid change-overs with validated cleaning, multi-purpose equipment design and lay-out that operate within a quality system specially designed for high levels of compliance yet of simple execution. This is what Hovione will be able to bring to the Cork site. "The combination of Hovione's 50 years of experience in API manufacture and contract manufacturing and the capabilities of the existing plant and compliance tradition of the Cork colleagues are a winning combination", said Noe Carreira, VP Manufacturing.

Hovione is an international group specializing in the development and compliant manufacture of active pharmaceutical ingredients, serving exclusively the pharmaceutical industry. With a 50-year track record, Hovione offers advanced technologies as well as APIs for all drug delivery systems, from oral to injectable and from inhalation to topical applications. With FDA inspected plants in Europe, the Far East and the US, Hovione is committed to the highest levels of service and quality. Specializing in complex chemistry and in particle engineering, Hovione offers all services related to the development, manufacture and pre-formulation of both new chemical entities (NCEs) and existing APIs for off-patent products.

For further information about Hovione, please visit the Hovione site at http://www.hovione.com or contact Corporate Communications (Isabel Pina, +351-21-982-9362, e-mail: hello@hovione.com).

'/>"/>

SOURCE Hovione Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Hovione Buys Drug Manufacturing Facility in China
2. Hovione Launches New Website
3. Hoviones Sales Grow 11%
4. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
5. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
6. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
7. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
8. Genzyme Begins Major Expansion of Boston Manufacturing Facility
9. Oxford Finance Corporation Closes $7 Million Debt Facility with Othera Pharmaceuticals
10. Tandem Labs New England Facility Doubles Discovery Support Capacity - Increasing Foothold in New England
11. Dendreon Secures $130 Million Committed Equity Financing Facility